Cambridge researchers awarded funding to establish Advanced Therapy Hub for the East of England
Posted:
Researchers at Cambridge University Hospitals (CUH) have been awarded almost £1.5 million from the National Institute for Health and Care Research (NIHR) to purchase specialist equipment required to research, test and deliver advanced therapies, such as stem cell therapies and CAR-T cell treatments for cancer, in Cambridge.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us